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338a Tuesday, February 10, 2015and thin filaments, (iii) the kinetics of Ca2þ binding to TnC involving two (skel-
etal) or one (cardiac) calcium binding sites and (iv) the McKillop-Geeves and
the continuous-flexible-chain models of thin filament regulation. Simulated
force-pCa relations closely follow the observations in skeletal and cardiac
muscles. Interestingly, the higher Hill coefficient observed in cardiac muscle
requires a longer confined persistence length (stiffer Tm) or a weaker interac-
tion of Tm with actin. Note that confined persistence length increases with in-
crease of Tm stiffness and decreases with strength of interaction of Tm with
actin. The simulations also predicted delayed rapid muscle relaxation after a
decrease of calcium concentration to pre- contraction level. The relaxation
delay time was much shorter in cardiac muscle than in skeletal muscle. This
is due to lower level of maximal activation of cardiac muscle compared to skel-
etal muscle, and therefore fewer TmTn units with more than one myosin bound.
But the cardiac muscle takes a longer time to relax completely. These differ-
ences can be clearly seen in a comparison of cardiac and skeletal muscle twitch
contractions. Using the same parameters, the simulations predicted the rise of
force during the twitch but relaxation was slower than predicted by simulations,
especially in cardiac muscle. This discrepancy invites further investigation of
the interplay between the actomyosin cycle and calcium regulation via TmTn
chain interactions with actin.
Supported by: NIH R01s AR048776 and DC 011528
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The converter has been proposed to be the myosin elastic element that sets
cross-bridge stiffness. According to most cross-bridge models, the elastic ele-
ment’s stiffness should directly influence muscle force generation. When the
elastic element is stretched by the power stroke, a stiffer element should in-
crease force generation. We tested these hypotheses by using the natural vari-
ation in converter regions found in different Drosophila muscle types. In
Drosophila, myosin isoforms are generated by alternative splicing from a sin-
gle myosin heavy chain gene. The converter region is encoded by five alterna-
tive versions of exon 11. We modified the gene to express alternative versions
in Drosophila indirect flight muscle (IFM) fibers instead of the wild-type 11a
version. Using 0.125% muscle length sinusoidal oscillations at 500 Hz, we
found that two of the four alternative versions, 11b (found in larval body
wall muscles) and 11c (jump muscle) significantly decreased fiber rigor stiff-
ness by 28% and 20%, respectively, indicating a decrease in cross-bridge stiff-
ness. The changes in rigor stiffness (elastic modulus) roughly correlated (r2 ¼
0.57) with force production by the fibers because 11b and 11c fibers also pro-
duced the lowest isometric tension. The correlation improved (r2 ¼ 0.71) when
it was corrected for the influence of cross-bridge duty ratio on isometric ten-
sion. Relative duty ratio was estimated from the frequency at which maximum
power was generated (fmax), and the muscle apparent rate constant 2pc. Con-
verters 11b, 11d, and 11e decreased fmax by 26%, 34% and 43%, respectively.
Thus, we conclude that the converter is at least part of the elastic element that
sets cross-bridge stiffness, and that this element helps set natural variation in
force production between muscle types. Supported by NIH grant R01
AR055611 to D.M.S.
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Muscle contraction is powered by the cyclic interaction of skeletal myosin mol-
ecules with actin filaments. Recent experiments suggest cooperative actions be-
tween myosin molecules, when part of an ensemble. In order to gain more
insight into the mechanism of intermolecular cooperativity between myosins
in a myofilament, displacements of actin generated by ~17 interacting myosins
embedded in myosin-rod cofilament were measured by optical tweezers.
Results showed stepwise displacements of actin (3-6 nm) under high loads of
~30 pN at every 1-2 ms. Dwell times gradually increased with increasing loads,
which is distinctively different from highly load-dependent characteristics of
dwell time observed in single myosins, implying that the number of force
generating myosins increases with increasing loads. These results suggest
that stepwise displacements may be generated by synchronous force genera-
tions of myosin molecules. In order to elucidate potential mechanisms of syn-chronous actions between myosins, we developed the simulation model,
consisting of 17 myosins arranged in series with six transition states defined
during actomyosin mechanochemical cycles. We have two types of model,
implemented with either one or two power strokes. Interestingly, two power
stroke model generates stepwise movements of actin at loads up to 30 pN,
but one power stroke model generates forces up to 20 pN. These differences
in force output are attributed to modulation of number of synchronous power
stroke motors. The numbers of synchronous power stroke motors increase
with increasing loads from 1.5 to 3 molecules in two power stroke model on
average, while they are virtually the same in one power stroke model. Com-
bined with results from both in-vitro and in-silico experiments, multiple power
stroke states associated with strain-dependent kinetics are essential for syn-
chronous force generations between myosins, that is a key feature for force
enhancement of myosin ensembles.
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The mechanisms behind the shortening-induced force depression (FD)
commonly observed in skeletal muscles remain unclear, but have been associ-
ated with sarcomere length non-uniformity and/or cross-bridge inhibition. The
purpose of this study was twofold: (i) to evaluate if FD is present in isolated
single sarcomeres, a preparation that eliminates sarcomere length non-
uniformities and (ii) to evaluate if FD is inhibited when single sarcomeres
are activated with MgADP, which biases cross-bridges into a strongly-bound
state. Single sarcomeres (n¼16) were isolated from rabbit psoas myofibrils
using two micro-needles (one compliant, one rigid), piercing the sarcomere
externally adjacent to the Z-lines. The sarcomeres were contracted isometri-
cally and subsequently shortened, in both Ca2þ- and MgADP-activating solu-
tions. Shortening in Ca2þ-activated samples resulted in a 27.44% 5 9.04%
force depression when compared to isometric contractions produced at similar
final sarcomere lengths (P> 0.001). There was no FD inMgADP-activated sar-
comeres (FD¼1.79%5 9.69%, P¼ 0.435). These results suggest that FD is
a sarcomeric property, and that is associated with an inhibition of myosin-actin
interactions.
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Background: Mutations in NEB, ACTA1, TPM2, TPM3, KBTBD13, KLHL40
and41 lead to thin filament myopathies, such as nemaline myopathy, congen-
ital fiber type disproportion and cap disease. A hallmark feature of these myop-
athies is muscle weakness. Here, we aimed to elucidate whether mutations in
NEB, ACTA1, TPM2, TPM3, KBTBD13, KLHL40 and KLHL41 affect the
maximal force generating capacity of muscle fibers. Subsequently,
by determining the sarcomere length-dependence of force, we investigated
whether changes in thin filament length contributed to muscle weakness.
Methods: Biopsies from NM, CFTD, and CAP patients (n¼39) with mutations
in NEB, ACTA1, TPM2, TPM3, KBTBD13, KLHL40 or KLHL41 were
compared to biopsies from healthy controls (n¼9). Using permeabilized muscle
fibers, maximal active tension was determined at incremental sarcomere
lengths (range 2.0-3.5 mm) to obtain the force-sarcomere length relationship.
Results: The maximal active tension (Fmax (in mN/mm2, mean5SEM)) was
significantly lower in biopsies from NEB (4655), ACTA1 (4854), TPM2
(7158), TPM3 (85510), KBTBD13 (7853), KLHL40 (2.850.2) and
KLHL41 (6354) patients compared to biopsies of controls (12957).
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TPM2, KBTBD 13, KLHL 40 and KLHL41 patients. In contrast, several pa-
tients with ACTA1 and NEB mutations showed a leftward shift of the force-
sarcomere length relationship indicating shorter thin filaments. Furthermore,
the slope of the descending limb of the force-sarcomere length relationship
in these patients is less steep than the slope of the CTRL curve, suggesting het-
erogeneity of thin filaments.
Conclusion: Our data suggest that mutations in NEB and ACTA1 result in
changes in thin filament length. Insights in the mechanisms underlying weak-
ness in patients with thin filament mutations are necessary to improve specific
treatment strategies.
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In striated muscle, the Z-band transmits force between contracting sarcomeres;
however, it is not merely a static anchor for actin filaments cross-linked by
alpha-actinin. Shimamoto observed a coordinated yielding of adjacent sarco-
meres in response to stretch, and its disruption by an alpha-actinin antibody
[1], indicating an active Z-band function and communication between adjacent
sarcomeres. We hypothesized the inter-sarcomeric communication must
involve a previously observed but poorly understood, reversible transition be-
tween two Z-band structures descriptively called small-square and basket-
weave [2], implying that alpha-actinin antibody must shift the equilibrium
between the two states. Using EM, we imaged Z-bands of chemically-
skinned relaxed rabbit soleus fibers and found that alpha-actinin antibody in-
duces complete conversion to the basketweave form of the Z-band, whereas
control fibers without antibody show the expected small square form. Since
the small-square form was previously associated with relaxed fibers and bas-
ketweave with contracted fibers [2], our results suggest that the basketweave
Z-band may store elastic energy, which can then favor or drive sarcomere
relaxation when the Z-band reverts to the small-square structure. By locking
the Z-band in the basketweave form, the antibody prevents the relaxation
and concomitant yielding of adjacent sarcomeres previously observed [1]. In
parallel mechanics experiments, we found antibody treatment did not interfere
with maximal calcium-activated isometric contraction and relaxation; however
isometric force and stretch-activation force during sub-maximal activation by
ADP were both reduced after antibody treatment. Thus, the alteration of
Z-band form by antibody only affects the muscle’s dynamic response to stretch
during partial activation.
1. Shimamoto, Y, et al. Inter-sarcomere coordination in muscle revealed
through individual sarcomere response to quick stretch. PNAS, 2009.
106(29):11954-9.
2. Goldstein, MA, et al. The Z-band lattice in skeletal muscle before, during and
after tetanic contraction. J Muscle Res, 1986. 7(6):527-36.
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At the molecular level, muscle contraction is powered by cyclic interactions be-
tween the molecular motor myosin and actin filaments. In vertebrate striated
muscle, this interaction is regulated by calcium binding to troponin and a result-
ing displacement of tropomyosin that renders binding sites on actin accessible
to myosin. Other proteins are involved in this process, but their roles are not as
well understood. One such protein is myosin binding protein-C (MyBP-C). The
cardiac isoform of this protein (cMyBP-C) has attracted recent attention
because of its role in heart disease. Despite this interest, its function is not
well understood, partly because in some assays it can have multiple effects.
In the actin motility assay, for example, cMyBP-C can have a dual, biphasic
activating/inhibitory effect.
To elucidate the function of cMyBP-C, we developed a mathematical model of
its interaction with the contractile proteins actin and myosin as well as the reg-
ulatory protein tropomyosin. This is, to our knowledge, the first mechanistic
model of cMyBP-C’s function. We used this model to fit published measure-
ments of cMyBP-C in the actin motility assay. These fits demonstrate that a
drag-activation-competition mechanism is consistent with the data, while
models lacking either drag or competition are not. These three effects can arise
simply from cMyBP-C binding to actin: cMyBP-C binding to actin both dis-
places tropomyosin (leading to activation) and also precludes concurrent
myosin binding (leading to competition). Additionally, if cMyBP-C is attachedto the flow cell surface, then binding to actin forms a transient link between the
actin filament and the surface, generating a viscous drag that further slows
motility. Future use of this model may help distinguish mechanistic effects
of cMyBP-C mutations that affect actin binding.
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We have used quantitative epifluorescence microscopy of fluorescent ATP to
measure single-nucleotide turnovers in skinned muscle fibers from mouse
models of female aging and hormone treatment. The loss of muscle strength
is an undesirable consequence of aging, often leading to frailty, disability,
and loss of independence for the elderly. Female muscle is additionally affected
by age due to reduction of ovarian hormone production with menopause. Estra-
diol (E2) is the key hormonal signal to skeletal muscle in females, and strength
loss is attenuated by E2 treatment. Single skeletal muscle fibers, isolated from
sham-operated or ovariectomized (OVX) mice with or without E2 treatment,
were incubated with mantATP. We measured decay of mantATP fluorescence
intensity in an ATP chase experiment, as pioneered by Cooke and colleagues
(Stewart et al., 2010; Cooke, 2011). These studies by Cooke unveiled a novel
regulated state of muscle myosin characterized by slow nucleotide turnover on
the order of minutes, termed the super-relaxed state (SRX). We detected a slow
phase of nucleotide turnover in approximately one-third of sham-operated
myosin heads, consistent with SRX. Turnover was substantially faster in
OVX fibers. Strikingly, the chronic lack of E2 in OVX fibers did not alter
the fraction of heads with slow turnover but rather decreased the turnover
time, suggesting disordering of SRX. E2 treatment in OVX mice partially
reversed this effect on SRX, while acute E2 treatment in the muscle bath had
no effect. All experiments were conducted with uniformly low myosin light
chain phosphorylation. We conclude that E2-mediated signaling regulates
slow ATP turnover and ordering of heads, probably via pathways distinct
from myosin phosphorylation status. Age- and hormone-related muscle func-
tional losses may be targetable at the level of thick filament structure for stra-
tegies to offset weakness and metabolic changes that occur with age.
Platform: Intracellular Channels and Calcium
Sparks and Waves
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Ryanodine receptors (RyRs) are large intracellular calcium-release channels
of the endo/sarcoplasmic reticulum that play a critical role in mediating
excitation-contraction coupling. Mutations within the skeletal muscle isoform
(RyR1) are associated with the pharmacogenetic disorder known as Malignant
Hyperthermia (MH) as well as congenital myopathies. Concurrently, mutations
within the cardiac (RyR2) isoform have been linked to life-threatening arrhyth-
mias, such as catecholaminergic polymorphic ventricular tachycardia (CPVT),
a potential precursor of sudden cardiac death. While recent high-resolution
structures have provided some mechanistic insights as to how mutations may
impact receptor function, this subject requires more work. The RyR1 amino-
terminal region contains an elaborate ionic interaction network embedded be-
tween its three domains which is key to the protein’s stability. Despite all the
ionic interaction partners being conserved within RyR2, the replacement of
two histidine residues with Tyr125 and Arg420 within RyR2 is enough to
abolish the ionic network and introduce a unique central anion binding site
within RyR2. Here, we present structural insights into the nature of the
RyR2 anion binding site. A 2.6A˚ crystal structure has been solved of the
amino-terminal RyR2 region (residues 1-547) into which two histidines,
Y125H and R420H, were introduced which abolished chloride binding but
which failed to restore the ionic network of its counterpart in RyR1. The
amino-terminal intrasubunit domain-domain interfaces of both RyR1 and
RyR2 are each targeted by over twenty disease-associated mutations. Here,
we provide the biochemical and structural characterization of a novel MH
RyR1 mutation, H113Q, and a potential CPVT-causing mutant, RyR2
R420W, both of which reside at a domain-domain interface.
